You are viewing the site in preview mode
Skip to main content
|
Metabolites
|
Fold change
|
VIPb
|
Adjusted P value
|
|---|
|
Annotemoyin 1
|
3.30
|
1.80
|
2.33E-4
|
|
Charine
|
3.08
|
1.58
|
4.36E-4
|
|
PA(18:2(9Z,12Z)/0:0)
|
3.08
|
1.23
|
2.30E-4
|
|
PE-Cer(d14:1(4E)/21:0)
|
3.08
|
1.33
|
1.03E-2
|
|
Oxamniquine
|
2.66
|
1.26
|
8.22E-3
|
|
31-hydroxy-32,35-anhydrobacteriohopanetetrol
|
2.62
|
1.90
|
5.30E-4
|
|
N-Stearoyl tyrosine
|
2.42
|
1.36
|
2.91E-3
|
|
LysoPE(0:0/18:3(6Z,9Z,12Z))
|
2.30
|
1.67
|
1.84E-2
|
|
32,35-anhydrobacteriohopaneterol
|
2.13
|
3.09
|
6.73E-4
|
|
Palmitoyl glucuronide
|
2.09
|
1.50
|
2.96E-3
|
|
Ascorbyl stearate
|
2.08
|
2.02
|
2.00E-4
|
|
2,4-Diphenyl-1-butene
|
2.06
|
1.81
|
3.39E-4
|
|
Cohibin A
|
2.03
|
3.05
|
6.43E-5
|
|
5beta-Cholestane-3alpha,7alpha,24-triol
|
2.03
|
2.00
|
6.08E-5
|
|
Methyl jasmonate
|
2.03
|
1.26
|
3.54E-2
|
|
23-methyl-5Z,9Z-tetracosadienoic acid
|
2.01
|
1.89
|
3.07E-4
|
|
25-Acetylvulgaroside
|
1.99
|
2.65
|
3.91E-3
|
|
Ambrettolic acid
|
1.96
|
4.13
|
2.22E-2
|
|
24-ethyl-5alpha-cholest-25-en-3alpha,12alpha,16alpha-triol
|
1.93
|
1.55
|
1.46E-3
|
|
3-Hydroxy-2-methyl-[R-(R,S)]-butanoic acid
|
0.34
|
3.58
|
5.55E-15
|
- a Metabolites with VIP > 1.20 and adjusted P < 0.05 were shown
- b VIP Variable importance in the projection
